sventura il primo Generalizzare clinical sarcoma research impact factor Acquisizione salario cartuccia
Molecular mechanisms underpinning sarcomas and implications for current and future therapy | Signal Transduction and Targeted Therapy
Frontiers | Intra-Abdominal Desmoplastic Small Round Cell Tumor: Current Treatment Options and Perspectives
A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis | Clinical Sarcoma Research | Full Text
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis | Clinical Sarcoma Research | Full Text
Clinical Sarcoma Research
Sarcoma | Hindawi
Clinical Sarcoma Research | Home page
Epidemiology of Soft Tissue Sarcoma and Bone Sarcoma inItaly: Analysis of Data from 15 Population-Based Cancer Registries
Sarcoma treatment in the era of molecular medicine | EMBO Molecular Medicine
The Journal of Pathology: Clinical Research - Wiley Online Library
Cancer Research Journal | Peer Reviewed | High Impact
Oncology and Cancer Therapeutics Journals | Oncology Research Journals
Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets | Nature Communications
Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma | Nature Communications
A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis | Clinical Sarcoma Research | Full Text
The Epidemiology of Sarcoma | Clinical Sarcoma Research | Full Text
Precision Sarcoma Research
Soft‐tissue sarcoma in adults: An update on the current state of histiotype‐specific management in an era of personalized medicine - Gamboa - 2020 - CA: A Cancer Journal for Clinicians - Wiley Online Library
A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis | Clinical Sarcoma Research | Full Text
Childhood Soft Tissue Sarcoma Treatment (PDQ®)–Health Professional Version - NCI
Soft Tissue Sarcoma Types, Staging & Treatment - Dana-Farber Cancer Institute | Boston, MA
Clinical Sarcoma Research
Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma | Nature Communications
High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapies - eBioMedicine
Survival impact of centralization and clinical guidelines for soft tissue sarcoma (A prospective and exhaustive population-based cohort) | PLOS ONE